[Reuters]–The US newspaper Washington Post (WP) received a report on the 19th that Moderna’s new coronavirus vaccine has a higher risk of developing myocarditis, especially among young adults, than Pfizer’s. , The US Food and Drug Administration (FDA) and other US drug and hygiene authorities are investigating.
Officials have not yet reached a conclusion on the matter, according to the WP.
In June, health officials added a warning to the documents accompanying the Moderna and Pfizer vaccines, indicating that young men are at a rare risk of developing myocarditis. On the other hand, he explained that the benefits of vaccination continue to outweigh the risks.
The WP said the Moderna vaccine could be 2.5 times more likely to develop myocarditis than the Pfizer vaccine, according to people familiar with the matter.
Canadian study data show that Moderna vaccines may have a higher risk of myocarditis than Pfizer vaccines in younger people, especially men under the age of 30.
No comments have been received from Moderna and the FDA on this report.
.
